PT Ciptarana Medika Tbk (ISX:DKHH) Research & Development: Rp Mil (TTM As of . 20)


What is PT Ciptarana Medika Tbk Research & Development?

PT Ciptarana Medika Tbk ISX:DKHH Research & Development is Rp Mil as of . 20. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PT Ciptarana Medika Tbk's Research & Development for the six months ended in . 20 was Rp0.00 Mil. PT Ciptarana Medika Tbk does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

PT Ciptarana Medika Tbk  (ISX:DKHH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT Ciptarana Medika Tbk Research & Development Related Terms

PT Ciptarana Medika Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT Ciptarana Medika Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Ciptarana Medika Tbk Research & Development Chart

PT Ciptarana Medika Tbk Annual Data
Trend
Research & Development

PT Ciptarana Medika Tbk Semi-Annual Data
Research & Development

PT Ciptarana Medika Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp Mil mean?
PT Ciptarana Medika Tbk (ISX:DKHH) has a Research & Development of Rp Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on PT Ciptarana Medika Tbk and its competitors.
Is PT Ciptarana Medika Tbk's Research & Development too high?
PT Ciptarana Medika Tbk's current Research & Development is Rp Mil.
How does PT Ciptarana Medika Tbk's Research & Development compare to HCA and THC?
PT Ciptarana Medika Tbk's Research & Development of Rp Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT Ciptarana Medika Tbk and its competitors. PT Ciptarana Medika Tbk's current Research & Development is Rp Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Ciptarana Medika Tbk stock overvalued right now?
PT Ciptarana Medika Tbk (ISX:DKHH) has a current Research & Development of Rp Mil. The current Research & Development is Rp Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT Ciptarana Medika Tbk (ISX:DKHH), the current Research & Development is Rp Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Ciptarana Medika Tbk Business Description

Address Jalan Siliwangi No. 139, Kec Cibadak, Jawa Barat, Kabupaten Sukabumi, IDN, 43351
PT Cipta Sarana Medika Tbk is a private hospital and part of the Djajakusumah Health Care Group. The company earns revenue from sale of medicine and medical supplies, when delivered to the patients.